The Only Way Out is Still Through:
Updating Our Outlook Amid the COVID-19 Crisis
In our December 2019 Global Market Outlook, State Street Global Advisors argued that trade war de-escalation, consumer and service sector resilience, and accommodative monetary policies were poised to bring about a modest global growth acceleration in 2020.
The COVID-19 crisis – a black swan event that has caused untold human suffering and hammered economies and markets around the globe – has clearly changed those dynamics. Nevertheless, while the baseline has shifted sharply lower, our assessment of how the global economy may fare as we emerge from this crisis is more optimistic than consensus. As this crisis unfolds, the sentiment we identified in our December Outlook seems, if anything, even more relevant now: The only way out is still through.
Macroeconomic Outlook: Worst hit to real activity is likely behind us; second half of 2020 brings gradual healing, 2021 should usher in a strong rebound
By March, earlier indications of improvement in global macro data collapsed into a retrenchment of unprecedented speed and magnitude. What began as a regional crisis originating in China quickly became a global pandemic, forcing strict lockdowns across the world. Economic activity collapsed almost instantly, as evidenced by unprecedented deterioration in a wide range of indicators, including purchasing managers’ indexes and US unemployment claims.
Confronted with a new reality, policymakers around the world quickly swung from the “comfortable where we are” message of early 2020 to a “whatever it takes to survive” mindset, focused on limiting the economic damage and preventing a liquidity crisis from morphing into a solvency crisis. The monetary and fiscal policy response to this crisis has been incredibly swift and powerful. Although stimulus always works with a lag, we believe this swift action will make a huge difference in how quickly economies will heal.
From the beginning, drawing on the experience of countries impacted early on, we described the COVID-19 crisis as a three-month peak impact shock, meaning that the worst of the economic collapse associated with it and the early stages of economic healing would be compressed within roughly a three-month timeline. As new case data shows infection curves bending in many places, and as the debate turns to the conditions and timeline for reopening, this remains our core assumption. 1
Even so, the economic hit will be severe, with many countries experiencing deep recessions and 2020 global growth the weakest since the Global Financial Crisis (GFC). Annual average GDP will mask truly extreme performance variation as we move through the year. After a weak first quarter and a horrid second quarter, we anticipate US and European economies will rebound sharply in the third quarter, with additional gains in the fourth quarter. This assumes that even in the event of a second flareup of the virus, we will have built enough capacity within the health system and made adequate provisions for personal protective equipment in order to address the health emergency. In addition, this assumes we will have made some progress toward acquiring herd immunity, so that further outbreaks would no longer necessitate the sort of blanket lockdowns that were imposed in the first instance.
Easy base comparisons will likely translate into abnormally high year-on-year growth rates during the first half of 2021, as lingering policy support converges with pent-up demand (and, possibly, with a biotech breakthrough) to drive sentiment and activity sharply higher. Given the tumultuous trajectory ahead, we believe there is a lot of value in embracing a two-year view. After the dashed expectations of 2020, we anticipate a modest return to growth in some regions by the second half of 2020, and that conditions will be in place for a powerful, V-shaped rebound into 2021. Overall, we would argue that diversified economies with less dependence on external demand and an ability to effectively coordinate fiscal and monetary policies (especially those with well-established reserve currencies) will be best positioned to weather this crisis.
These expectations are based in part on the swift response of policymakers and central banks. Here economies are reaping the benefits of past experience. Most of today’s tools were identified and incubated during the GFC and thus, in the current crisis, were “off-the-shelf” options that could be deployed within days. We have seen dramatic rate cuts, massive scale-ups of repo operations, re-activation of crisis-era liquidity mechanisms, and the resumption, expansion and broadening of quantitative easing. New tools are being developed as well; the Fed, for example, has initiated a new facility that essentially amounts to direct business lending. Meanwhile, governments around the world are pushing through enormous fiscal packages.
Even as vast sums are pumped into the global economy, inflation is probably the least of our worries, at least for now. Despite likely supply chain disruptions and some bottlenecks in the months to come, we view COVID-19 as largely a deflationary force in the near term. Plunging oil prices alone are enough to drive inflation down across economies; our new forecasts reflect this. Whether this crisis is deflationary over the medium to long term is unclear, as we wait to see whether reshoring to higher labor cost locations wins out over tech-driven innovation in the competition to bolster crisis-exposed supply chains. Whether inflation flares up down the line will also be the litmus test on whether MMT 2- type policy responses are viable.
Emerging market economies, which tend toward greater dependency on commodities including oil, metals, and agricultural products, may suffer an especially deep decline in GDP. Steep capital outflows are driving currency depreciation, leading debt servicing obligations to become more onerous and increasing the risk of default. EM countries with the strongest capacity for policy implementation — for delivery of effective health care services and for effective and sizable stimulus— are likely to fare far better, through this episode and beyond.
Our current asset allocation: Long growth assets with tactical hedges; opportunities in credit
Bearing in mind our broad expectations for the global economy and the unprecedented monetary and fiscal support taking shape across many economies, our current portfolio allocation continues to be long select equities and other risk assets, expressing a view in global large-cap equities and credit. We are slightly short fixed income overall; within that fixed income allocation, we are neutral to slightly short duration with a preference for credit over rates as companies move to preserve cash. Even as we’ve built up equity exposures over the past several months, we’ve continued to construct tactical hedges in gold, Treasuries, and cash.
We have retained a small position in European and EM assets, not because we hold a strong near-term viewpoint on Europe and EM prospects, but rather in recognition of the fact that cyclical bounces can occur in this market environment. Our proprietary Market Regime Indicator 3 has persisted in crisis range for some time. When this is the case, we tend to position our portfolios for a short-term reversal.
In equity markets, we favor North American equities for three main reasons. First, although it will be some time before analysts’ assessments of COVID-19’s impact are fully reflected in earnings assessments, North American companies have so far downgraded earnings less often than their counterparts elsewhere. Second, North American equities tend to be overweight quality. In the aftermath of the GFC, balance sheet strength was a leading indicator of equity performance. We believe the same will principle will hold as this crisis unfolds. Finally, we expect the lower-for-longer interest rate environment to broadly benefit defensive
sectors, where the US also has an advantage over other regions.
In fixed income, we see opportunities in both high yield (HY) and investment grade (IG) credit, as spreads between Treasuries and both HY and IG corporate issues have widened during the crisis. Prudent investors can find attractive opportunities in this environment that may allow them to benefit from the subsequent narrowing of spreads as conditions return to normal. It is, of course, important for investors to be well informed of potential outcomes when seeking to invest in times of crisis.
Liquidity issues are at the forefront in emerging markets, as investors have treated EM equities and EM debt alike as risk assets during the crisis, resulting in steep capital outflows. Valuations have improved across EM asset classes since we issued our last outlook, and EM economies have capacity to continue fiscal and monetary interventions, which should help to support fundamentals in the near term. But EM assets will require support from developed markets; resumption of growth in developed
markets, a rebound in oil prices, and reduction in US dollar strength are
critical for a rebound in EM. We prefer local-currency to hard-currency EM
debt, and encourage investors to look closely at their EM equity allocations.
Closing Thoughts: Key Signposts to Watch
Looking ahead to the coming weeks and months, it’s clear that a return to economic growth will depend on the trajectory and duration of this grave, global health crisis. As developments unfold, these are some of the signposts we’re watching as key prerequisites of a return to investor confidence:
How successfully countries and regions strike a balance between the public health burden and the timing of lockdown exits
Whether we achieve significant biotech advances toward an effective drug treatment and/or vaccine
Whether fiscal stimulus packages manage to mitigate the negative economic impact of the crisis
How well central bank programs work to ensure liquidity
What shape the recovery will take as economies operate in a semi-constrained environment
We will continue to update our outlook in the months and weeks to come.
1 This does not mean that we believe that the pandemic will be over within three months, but rather that enough progress can be made within about three months to bring each localized outbreak that does occur under control. Progress in containing each outbreak allows for the gradual relaxation of social distancing restrictions in that area, which in turn allows economic activity to resume selectively.
2 Modern Monetary Theory. MMT argues, in very broad strokes, that countries that issue their own currencies should be able to print all the money they need to fund programs, provided they avoid generating inflation.
3 The Market Regime Indicator (MRI) is a proprietary multi-asset class model designed to characterize risk appetites within the capital markets. The “crisis” range represents extremely high risk aversion.
The information provided does not constitute investment advice as such term is defined under the Markets in Financial Instruments Directive (2014/65/EU) or applicable Swiss regulation and it should not be relied on as such. It should not be considered a solicitation to buy or an offer to sell any investment. It does not take into account any investor's or potential investor’s particular investment objectives, strategies, tax status, risk appetite or investment horizon. If you require investment advice you should consult your tax and financial or other professional advisor. All material has been obtained from sources believed to be reliable. There is no representation or warranty as to the accuracy of the information and State Street shall have no liability for decisions based on such information.
The views expressed in this material are the views of State Street Global Advisors through the period April 30, 2020 and are subject to change based on market and other conditions. This document contains certain statements that may be deemed forward-looking statements. Please note that any such statements are not guarantees of any future performance and actual results or developments may differ materially from those projected.
The trademarks and service marks referenced herein are the property of their respective owners. Third party data providers make no warranties or representations of any kind relating to the accuracy, completeness or timeliness of the data and have no liability for damages of any kind relating to the use of such data.
Investing involves risk including the risk of loss of principal.
The whole or any part of this work may not be reproduced, copied or transmitted or any of its contents disclosed to third parties without SSGA's express written consent.
All the index performance results referred to are provided exclusively for comparison purposes only. It should not be assumed that they represent the performance of any particular investment.
Equity securities may fluctuate in value in response to the activities of individual companies and general market and economic conditions.
Bonds generally present less short-term risk and volatility than stocks, but contain interest rate risk (as interest rates raise, bond prices usually fall); issuer default risk; issuer credit risk; liquidity risk; and inflation risk. These effects are usually pronounced for longer-term securities. Any fixed income security sold or redeemed prior to maturity may be subject to a substantial gain or loss.
Investing in high yield fixed income securities, otherwise known as "junk bonds", is considered speculative and involves greater risk of loss of principal and interest than investing in investment grade fixed income securities. These Lower-quality debt securities involve greater risk of default or price changes due to potential changes in the credit quality of the issuer.
Increase in real interest rates can cause the price of inflation-protected debt securities to decrease. Interest payments on inflation-protected debt securities can be unpredictable.
There are risks associated with investing in Real Assets and the Real Assets sector, including real estate, precious metals and natural resources. Investments can be significantly affected by events relating to these industries.
Investing in foreign domiciled securities may involve risk of capital loss from unfavorable fluctuation in currency values, withholding taxes, from differences in generally accepted accounting principles or from economic or political instability in other nations. Investments in emerging or developing markets may be more volatile and less liquid than investing in developed markets and may involve exposure to economic structures that are generally less diverse and mature and to political systems which have less stability than those of more developed countries.
This information is for informational purposes only, not to be construed as investment advice or a recommendation or offer to buy or sell any security. Investors should always obtain and read an up-to-date investment services description or prospectus before deciding whether to appoint an investment manager or to invest in a fund. Any views expressed herein are those of the author(s), are based on available information, and are subject to change without notice. Individual portfolio management teams may hold different views and may make different investment decisions for different clients. There are no guarantees regarding the achievement of investment objectives, target returns, portfolio construction, allocations or measurements such as alpha, tracking error, stock weightings and other information ratios. The views and strategies described may not be suitable for all investors. SSGA does not provide tax or legal advice. Prospective investors should consult with a tax or legal advisor before making any investment decision. Investing entails risks and there can be no assurance that SSGA will achieve profits or avoid incurring losses.
Performance quoted represents past performance, which is no guarantee of future results. Investment return and principal value will fluctuate, so you may have a gain or loss when shares are sold. Current performance may be higher or lower than that quoted.
Images of NYSE Group, Inc. are used with permission of NYSE Group, Inc. Neither NYSE Group, Inc. nor its affiliated companies sponsor, approve of or endorse the contents of this program. Neither NYSE Group, Inc. nor its affiliated companies recommend or make any representation as to possible benefits from any securities or investments.